ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #707Top JournalReview JournalHybrid

Current Opinion in Immunology

Acronym:coimmu
•
Abbreviation (ISO):CURR. OPIN. IMMUNOL
•
Identifier (ISSN):0952-7915(Print)/1879-0372(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
5.6↓ -0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Opinion in Immunology

WoS Q1
368117.9320187.6720197.2920207.4920217.272022720236.620245.820255.62026
Annual Impact Factor Metric
Current (2026):5.6
Scopus SJR & RankScopus Q1
3.01
#707

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
218

218 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
105articles/year
39.86% Gold OA•0% Original Research

Aims & Scope

Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed. In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. Current Opinion in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.

Topics Covered (Recognized by AI)
Biology99.7%Medicine85.5%Genetics82.4%Immunology80.6%Immune system65.5%Chemistry65%Biochemistry63.6%Internal medicine58.3%Cell biology44.3%Antigen39.1%Gene36.8%Computational biology33.8%Pathology27.8%T cell26.5%Receptor26.3%Antibody26.2%In vitro20.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank42/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank109/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.6
Articles / Year108
Total Citations71
2025
IF5.8
Articles / Year145
Total Citations625
2024
IF6.6
Articles / Year73
Total Citations721
2023
IF7
Articles / Year89
Total Citations1,690
2022
IF7.268
Articles / Year85
Total Citations2,612

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #707Scopus Q1SCImago Profile
Scopus Coverage:1988-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
3.01

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.70

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,036 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,602
3-Year Documents238
Citable Documents226

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate42.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Opinion in Immunology (acronym: coimmu, abbr: CURR. OPIN. IMMUNOL, ISSN: 0952-7915) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 1988. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.010 (Q1), an H-index of 218.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 105 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,036 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
1988
Indexing & Databases
SCIEScopusPubMed
Editorial Address
CURRENT BIOLOGY LTD, 84 THEOBALDS RD, LONDON, ENGLAND, WC1X 8RR

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8aa93fbf-7769-49eb-b557-2f88dc5fbe0a
Database Updated: 2026-10-16